Elizabeth L. Alexander

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.

P. Pang, A. Cathcart, E. Mogalian, 2021, The New England journal of medicine.

CPT: Pharmacometrics & Systems Pharmacology

Ghent, M. Jamei, D. Ashcroft, 2013, CPT: pharmacometrics & systems pharmacology.

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial

P. Pang, Maria L. Agostini, E. Mogalian, 2023, Open forum infectious diseases.

Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab

P. Pang, A. Cathcart, N. Scott, 2021, medRxiv.

Antibody therapy reverses biological signatures of COVID-19 progression

A. Telenti, L. Purcell, M. C. Maher, 2021, Cell Reports Medicine.

Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial

P. Pang, Maria L. Agostini, A. Nader, 2023, medRxiv.